{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=5&sponsor=Boehringer+Ingelheim", "query": { "sponsor": "Boehringer Ingelheim", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 673, "total_pages": 68, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=6&sponsor=Boehringer+Ingelheim&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=4&sponsor=Boehringer+Ingelheim&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T10:14:44.218Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04919499", "title": "A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetic Retinopathy" ], "interventions": [ { "name": "BI 765128", "type": "DRUG" }, { "name": "Sham comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-07-30", "completion_date": "2023-08-07", "has_results": true, "last_update_posted_date": "2024-11-21", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 11, "location_summary": "Bakersfield, California • Sacramento, California • Walnut Creek, California + 7 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04919499" }, { "nct_id": "NCT04978493", "title": "A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "BI 706321", "type": "DRUG" }, { "name": "Ustekinumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 49, "start_date": "2021-12-02", "completion_date": "2024-08-08", "has_results": true, "last_update_posted_date": "2025-09-04", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 15, "location_summary": "Northridge, California • Hialeah, Florida • Inverness, Florida + 12 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Inverness", "state": "Florida" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04978493" }, { "nct_id": "NCT01330316", "title": "A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "BI 201335", "type": "DRUG" }, { "name": "PegIFN/RBV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 119, "start_date": "2011-07", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2016-06-30", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 20, "location_summary": "Birmingham, Alabama • North Little Rock, Arkansas • Los Angeles, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01330316" }, { "nct_id": "NCT00152971", "title": "Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthroplasty, Replacement, Knee", "Thromboembolism" ], "interventions": [ { "name": "Dabigatran Dose 1 - day 2 to completion", "type": "DRUG" }, { "name": "Dabigatran Dose 1 - day 1", "type": "DRUG" }, { "name": "Dabigatran Dose 2 - day 2 to completion", "type": "DRUG" }, { "name": "Dabigatran Dose 2 - day 1", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2615, "start_date": "2004-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-05", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 59, "location_summary": "Birmingham, Alabama • Northport, Alabama • Tucson, Arizona + 48 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00152971" }, { "nct_id": "NCT04424290", "title": "HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetic Retinopathy" ], "interventions": [ { "name": "BI 764524", "type": "DRUG" }, { "name": "Sham control of BI 764524", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2020-06-12", "completion_date": "2023-04-28", "has_results": true, "last_update_posted_date": "2024-05-22", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 13, "location_summary": "Dothan, Alabama • Beverly Hills, California • Palo Alto, California + 10 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Carmel", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04424290" }, { "nct_id": "NCT01132313", "title": "Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "BI 207127", "type": "DRUG" }, { "name": "BI 201335", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" }, { "name": "BI 207217", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 488, "start_date": "2010-05", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2016-02-01", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 12, "location_summary": "La Jolla, California • San Diego, California • San Francisco, California + 9 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Palm Harbor", "state": "Florida" }, { "city": "Valparaiso", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01132313" }, { "nct_id": "NCT02003573", "title": "Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia, Myeloid, Acute" ], "interventions": [ { "name": "decitabine iv", "type": "DRUG" }, { "name": "volasertib iv infusion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 13, "start_date": "2014-01-29", "completion_date": "2016-05-15", "has_results": true, "last_update_posted_date": "2019-01-31", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 3, "location_summary": "New Haven, Connecticut • St Louis, Missouri • Houston, Texas", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02003573" }, { "nct_id": "NCT04153929", "title": "A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "BI 456906", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 413, "start_date": "2020-04-30", "completion_date": "2021-11-04", "has_results": true, "last_update_posted_date": "2022-11-29", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 31, "location_summary": "Huntington Park, California • Los Angeles, California • Northridge, California + 27 more", "locations": [ { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Lakeland", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04153929" }, { "nct_id": "NCT05870956", "title": "Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Idiopathic Pulmonary Fibrosis" ], "interventions": [ { "name": "Nintedanib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "66 Years", "maximum_age": null, "sex": "ALL", "summary": "66 Years and older" }, "enrollment_count": 1798, "start_date": "2023-05-16", "completion_date": "2023-06-30", "has_results": true, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 1, "location_summary": "Milton, Massachusetts", "locations": [ { "city": "Milton", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05870956" }, { "nct_id": "NCT03166631", "title": "A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms", "Neoplasm Metastasis", "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "BI 891065", "type": "DRUG" }, { "name": "BI 754091", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2017-09-08", "completion_date": "2020-10-28", "has_results": true, "last_update_posted_date": "2024-11-19", "last_synced_at": "2026-10-11T10:14:44.218Z", "location_count": 3, "location_summary": "Sarasota, Florida • Nashville, Tennessee • Milwaukee, Wisconsin", "locations": [ { "city": "Sarasota", "state": "Florida" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03166631" } ] }